Original Research
Published on 09 Mar 2021
Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
in Cancer Molecular Targets and Therapeutics
- 3,463 views
- 16 citations
Original Research
Published on 09 Mar 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 09 Mar 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 09 Mar 2021
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 09 Mar 2021
in Cancer Molecular Targets and Therapeutics
Perspective
Published on 08 Mar 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 04 Mar 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 04 Mar 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 02 Mar 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 02 Mar 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 26 Feb 2021
in Cancer Molecular Targets and Therapeutics
Review
Published on 26 Feb 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Feb 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Feb 2021
in Cancer Molecular Targets and Therapeutics
General Commentary
Published on 25 Feb 2021
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 25 Feb 2021
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 25 Feb 2021
in Cancer Molecular Targets and Therapeutics